Clinical and Laboratory Findings of HIV-1–Infected Patients
Patient No. . | Age (yr)/ Sex . | CD4+ (cells/μL) . | CD8+ (cells/μL) . | CD4+/CD8+ . | Viremia (RNA copies/mL) . | Therapy . | STAT Activation . |
---|---|---|---|---|---|---|---|
1 | 30/F | 400 | 374 | 1.06 | <400 | NA | + |
2 | 34/M | 714 | 1,039 | 0.68 | 32,661 | NA | + |
3 | 35/M | 559 | 851 | 0.65 | <400 | NA | + |
4 | 35/M | 326 | 1,410 | 0.23 | 233,063 | NA | + |
5 | 41/M | 480 | 3,473 | 0.13 | 108,294 | ddI, AZT | + |
6 | 40/M | 206 | 1,630 | 0.12 | 100,828 | d4T | + |
7 | 45/M | 477 | 497 | 0.95 | 947 | ddI + 3TC | + |
8 | 23/F | 332 | 286 | 1.1 | <400 | AZT + ddI | + |
9 | 62/F | 510 | 384 | 1.33 | 93,814 | AZT + 3TC | + |
10 | 45/F | 339 | 571 | 0.59 | 111,932 | AZT + ddI | + |
11 | 47/M | 382 | 685 | 0.55 | 134,688 | d4T + ddI | − |
12 | 45/M | 273 | 803 | 0.33 | 37,791 | AZT + ddI | − |
13 | 40/M | 335 | 1,041 | 0.32 | 23,253 | AZT + ddI | − |
14 | 46/M | 620 | 1,514 | 0.40 | 4,360 | NA | − |
15 | 31/F | 517 | 1,716 | 0.30 | <400 | Triple | + |
16 | 54/M | 427 | 1,076 | 0.39 | <400 | Triple | + |
Patient No. . | Age (yr)/ Sex . | CD4+ (cells/μL) . | CD8+ (cells/μL) . | CD4+/CD8+ . | Viremia (RNA copies/mL) . | Therapy . | STAT Activation . |
---|---|---|---|---|---|---|---|
1 | 30/F | 400 | 374 | 1.06 | <400 | NA | + |
2 | 34/M | 714 | 1,039 | 0.68 | 32,661 | NA | + |
3 | 35/M | 559 | 851 | 0.65 | <400 | NA | + |
4 | 35/M | 326 | 1,410 | 0.23 | 233,063 | NA | + |
5 | 41/M | 480 | 3,473 | 0.13 | 108,294 | ddI, AZT | + |
6 | 40/M | 206 | 1,630 | 0.12 | 100,828 | d4T | + |
7 | 45/M | 477 | 497 | 0.95 | 947 | ddI + 3TC | + |
8 | 23/F | 332 | 286 | 1.1 | <400 | AZT + ddI | + |
9 | 62/F | 510 | 384 | 1.33 | 93,814 | AZT + 3TC | + |
10 | 45/F | 339 | 571 | 0.59 | 111,932 | AZT + ddI | + |
11 | 47/M | 382 | 685 | 0.55 | 134,688 | d4T + ddI | − |
12 | 45/M | 273 | 803 | 0.33 | 37,791 | AZT + ddI | − |
13 | 40/M | 335 | 1,041 | 0.32 | 23,253 | AZT + ddI | − |
14 | 46/M | 620 | 1,514 | 0.40 | 4,360 | NA | − |
15 | 31/F | 517 | 1,716 | 0.30 | <400 | Triple | + |
16 | 54/M | 427 | 1,076 | 0.39 | <400 | Triple | + |
Abbreviations: NA, not applicable (naive individuals); Triple, triple therapy, 2 reverse transcriptase inhibitors (RTI) + 1 protease inhibitor (PI).